Spectramedix India Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 1.00 M
- Company Age 10 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 43.08%
- Profit Growth 60.94%
- Ebitda -21.09%
- Net Worth 50.24%
- Total Assets 44.57%
About Spectramedix India
Spectramedix India Private Limited (SIPL) is a leading Private Limited Foreign Company Incorporated In India incorporated in India on 01 August 2014 and has a history of Ten years and six months. Its registered office is in Delhi, India.
The Company is engaged in the Information Technology Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M, as per Ministry of Corporate Affairs (MCA) records.
Rajiv Lakhanpal, Sushma Lakhanpal, and Mukesh Gupta serve as directors at the Company.
Company Details
- Location
Delhi, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U72200DL2014FTC269795
- Company No.
269795
- Company Classification
Private Limited Foreign Company Incorporated In India
- Incorporation Date
01 Aug 2014
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Spectramedix India?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rajiv Lakhanpal  | Director | 01-Aug-2014 | Current |
| Sushma Lakhanpal | Director | 01-Aug-2014 | Current |
Mukesh Gupta  | Director | 24-Dec-2018 | Current |
Financial Performance of Spectramedix India.
Spectramedix India Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 43.08% increase. The company also saw a substantial improvement in profitability, with a 60.94% increase in profit. The company's net worth Soared by an impressive increase of 50.24%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Spectramedix India?
In 2023, Spectramedix India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Spectramedix India?
Spectramedix India has a workforce of 121 employees as of Mar 29, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Spectramedix India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Spectramedix India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
